Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents

AIDS Research and Human Retroviruses

Volumn 17, Issue 2, 2001, Pages 161-168

  Rodenburg, C M ^a   Li, Y ^a   Trask, S A ^a   Chen, Y ^a   Decker, J ^b   Robertson, D L ^c   Kalish, M L ^d   Shaw, G M ^a,b,e   Allen, S ^b   Hahn, B H ^a,e   Gao, F ^a,b   Osmanov, S ^f   Jacobs, L ^f   Esparza, J ^f   Galvao Castro, B ^g   Shao, Y ^h   Samuel, N ⁱ   Maayan, S ^j   Bobkov, A ^k   Smolskaya, T ^l   Makgoba, W ^m   Williamson, C ⁿ   M'Boup, S ^o   Mhalu, F ^p   Auewarakul, P ^q   Kaleebu, P ^r   Sempala, S ^r   Dietrich, U ^s   Von Briesen, H ^s   Nick, S ^t   Nubling, M ^t   Halbauer, J ^t   Hamouda, O ^u   Kucherer C ^u   Riedl, R ^v   Wolf, H ^w   Hoelscher, M ^x   Holmes, H ^y   Beddows, S ^z   Giraldo, G ^aa   Buonaguro, L ^aa   Scarlatti, G ^ab   Salminen, M ^ac   Van der Groen, G ^ad   Barre Sinoussi F ^ae   Peeters, M ^af   Fenyo E ^ag   Lopez Galindez C ^ah   Lukashov, B ^ai   Bradac, J ^aj   Mullins, J ^ak   Hahn, B ^b   Abimiku, A ^al   Berman, P ^am   Birx, D ^an   Chappey, C ^ao   Ferrari, G ^ap   Kalish, M ^d   McCutchan, F ^aq   Zolla Pazner, S ^ar   more..

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e University of Alabama at Birmingham   (United States)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g INSTITUTO OSWALDO CRUZ   (Brazil)

^h National AIDS Reference Laboratory   (China)

ⁱ Tamilnadu Dr MGR Medical University   (India)

^j HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^k INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^l ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

^m SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

ⁿ UNIVERSITY OF CAPE TOWN   (South Africa)

^o UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^p Muhumbili Medical Centre   (Tanzania)

^q MAHIDOL UNIVERSITY   (Thailand)

^r UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^s INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^t PAUL EHRLICH INSTITUT   (Germany)

^u ROBERT KOCH INSTITUTE   (Germany)

^v Riedl and partner   (Germany)

^w UNIVERSITY OF REGENSBURG   (Germany)

^x UNIVERSITY OF MUNICH   (Germany)

^y NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^z IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^aa NATIONAL CANCER INSTITUTE   (Italy)

^ab SAN RAFFAELE HOSPITAL   (Italy)

^ac NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ad INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^ae INSTITUT PASTEUR   (France)

^af INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^ag KAROLINSKA INSTITUTE   (Sweden)

^ah INSTITUTO DE SALUD CARLOS III   (Spain)

^ai UNIVERSITY OF AMSTERDAM   (Netherlands)

^aj NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^ak UNIVERSITY OF WASHINGTON   (United States)

^al UNIVERSITY OF MARYLAND   (United States)

^am VaxGen Inc   (United States)

^an WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^ao NATIONAL INSTITUTES OF HEALTH   (United States)

^ap Medical Center   (United States)

^aq Jackson Foundation Research Laboratory   (United States)

^ar NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CLONE; ENHANCER REGION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; VIRUS GENOME; VIRUS ISOLATION;

ADULT; BASE SEQUENCE; BRAZIL; CHINA; FEMALE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; GENE PRODUCTS, REV; GENOME, VIRAL; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; INDIA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ALIGNMENT; SOUTH AFRICA; TANZANIA;

EID: 0035141859     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220150217247     Document Type: Article

References (26)

1. HIV-1 nomenclature proposal
2. Geographical distribution of HIV-1 group O viruses in Africa
3. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development
4. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers
5. Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes
6. Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization
7. Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development
8. The implications of antigenic diversity for vaccine development
9. Accelerating the development and future availability of HIV-1 vaccines: Why, when, where, and how?
10. Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C
11. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1
12. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination
13. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: A set of 23 full-length clones from Botswana
14. A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations
15. env gene sequences of primary HIV type 1 isolates of subtypes B, C, D, E, and F obtained from the World Health Organization Network for HIV Isolation and Characterization
16. Two subtypes of HIV-1 among injection-drug users in southern China
17. HIV-1 infection in China
18. Recombination in HIV-1
19. Intersubtype recombinant HIV-1 sequences
20. Overland heroin trafficking routes and HIV-1 spread in south and southeast Asia
21. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1
22. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes
23. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: Syncytium-inducing variants seem rare among subtype C HIV-1 viruses
24. Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India